Xpresspa Group Inc (XSPA)

With risk-return not in your favor, steer clear of these 8 penny stocks, all of which could see big declines as the new year unfolds. Chesapeake Energy (OTCMKTS:CHKAQ) Genius Brands (NASDAQ:GNUS) Hertz Global Holdings (OTCMKTS:HTZGQ) Remark Holdings (NASDAQ:MARK) Ocugen (NASDAQ:OCGN) StoneMor (NYSE:STON) VBI Vaccines (NASDAQ:VBIV) XspresSpa (NASDAQ:XSPA)

XpresSpa Stock Is Back to Its Lows for Good Reason

By InvestorPlace Research Staff Jan 5, 2021

The optimism toward XSPA stock never made much sense given that normalcy eventually would return. Investors finally have figured that out.

7 Names In Danger of Joining the Shamed Ranks of Delisted Stocks

By Todd Shriber, InvestorPlace Contributor Dec 31, 2020

Some investors just can't help themselves. They love companies with low share prices. However, those equities come with an array of risks, including increased probability that when the $5 and $1 marks are breached, these names can join the ranks of delisted stocks.

XpresSpa Is Trying To Turn Around, But Its Legs and Arms Are Tied

By Mark R. Hake, CFA Dec 30, 2020

XpresSpa is trying to turn around, but it's tied. XSPA stock won’t be able to turn around until the company can start recognizing revenue.

XpresSpa Is a Multidimensional Airport-Testing Play

By Muslim Farooque Dec 30, 2020

XSPA stock is more than just a Covid-19 testing play, as XpresSpa plans to evolve into a more well-rounded airport-testing company.

XpresSpa Stock Is More Trouble Than It’s Worth

By InvestorPlace Research Staff Dec 16, 2020

Already struggling before the pandemic, XSPA stock is definitely one to avoid. Don't count on it for an air-travel recovery play.

XpresSpa Bears Might Need Their Own Immunization

By Josh Enomoto, InvestorPlace Contributor Dec 16, 2020

Given the huge technical losses suffered by XSPA stock, it’s no wonder why so many are abandoning ship. However, XpresSpa also remains surprisingly relevant despite the vaccine development.

Low-Priced XpresSpa Stock Deserves to Be Higher

By Louis Navellier and the InvestorPlace Research Staff Dec 14, 2020

The market might not fully appreciate XSPA stock's upside potential as the need for Covid-19 testing isn't going away.

XpresSpa Stock Presents Too Many Concerns to Be a Buy

By InvestorPlace Research Staff Nov 10, 2020

XSPA is down almost 80% from its June highs for a reason. Investors should continue to avoid this name over future concerns for its business.

To Succeed, XpresSpa Needs a Lot to Go Its Way

By Todd Shriber, InvestorPlace Contributor Nov 6, 2020

After XpresSpa went from spa operator to coronavirus testing center provider, XpresSpa stock is quite risky at this point.

XpresSpa Is Still a Covid-19 Testing Play — But Also Much More

By Louis Navellier and the InvestorPlace Research Staff Nov 4, 2020

For most of 2020, XpresSpa stock was primarily a Covid-19 testing investment. But recent changes suggest more variety in this company -- and could signal a positive impact on shares.